Catalog Number 3430.24SF1 |
Device Problem
Break (1069)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/28/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
The complaint is under investigation.In case of a product return, the device will be investigated, otherwise we will review the device history record, and/or any log files if available, or try to replicate the problem on similar product.As investigations on the actual product or representative sample of a batch may alter the device, we request to inform us within 7 days after submission of this report, in case the investigations that alter the device should be halted until approval of the nca, as per article 89 of eu-mdr.
|
|
Event Description
|
We have been informed that during procedure, the needle fractured during phaco emulsification.The surgeon recovered the part that was floating in the anterior chamber and finished the surgery with a new needle.No report that patient harm occurred, or surgery was prolonged or delayed.
|
|
Event Description
|
We have been informed that during procedure, the needle fractured during phaco emulsification.The surgeon recovered the part that was floating in the anterior chamber and finished the surgery with a new needle.No report that patient harm occurred, or surgery was prolonged or delayed.
|
|
Manufacturer Narrative
|
Since the involved reusable 2.4 mm 30° straight flared phaco needle was not returned, no examination could be performed.As the manufacturing date of the reusable needle is unknown, an investigation pertinent to the manufacturing records was not possible either.Without any proper investigation, the cause of the failure remains unknown.In general, it should be noted that insufficient irrigation, and therefore insufficient cooling, is the most likely cause for the phaco needle to break during use.Since lack of irrigation may have various causes, including, but not limited to improper placement of the phaco sleeve or unfavorable settings, a main contributor the the failure could not be determined.The risk identified is included in the risk management documentation.Trend analysis indicates that the product is performing within anticipated rates.Complaints will be closely monitored to identify any significant adverse trends.Since a manufacturer related failure was not confirmed, no remedial action/corrective action/preventive action/field safety corrective action (fsca) was initiated.The analysis includes all complaints with failure mode as reported ph-needle-broken (rep) and, since breaking is not limited to a specific phaco needle type, the distribution figures of all phaco needles.
|
|
Search Alerts/Recalls
|
|